ArticleFrontiers in pharmacology2025

Case report: Aumolertinib plus gumarontinib in a patient with EGFR mutated non-small-cell lung cancer harboring acquired MET amplification following progression on afatinib plus crizotinib.

Jia-Jun Hui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.